Recruiting
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
NCT07194005
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China